secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHINA PHARMA HOLDINGS, INC. (CPHI)
CIK:        0001106644
Form:       8-K
Filed at:   2023-12-19T23:59:59+00:00
Accession:  0001213900-23-096920
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

China Pharma shareholders OK reverse split up to 1:10; NYSE compliance partially restored
--------------------------------------------------------------------------------

- Shareholders re-elected directors Bennett, Zhang, Dong; approved amendment to 2010 long-term incentive plan.
- Reverse stock split up to 1:10 approved; board retains discretion on whether and when to effect.
- NYSE American confirmed compliance with continued listing standards 1003(a)(ii) and (iii); non-compliance with Section 1003(f)(v) persists.
- Company remains under '.BC' indicator; NYSE may initiate delisting if non-compliance recurs within 12 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106644/000121390023096920/0001213900-23-096920-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106644/000121390023096920/ea190332-8k_chinapharm.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-096920

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer